Log In
Print
BCIQ
Print
Print this Print this
 

BBI-2111

  Manage Alerts
Collapse Summary General Information
Company Brickell Biotech Inc.
DescriptionAnti-inflammatory small peptide
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationDermatitis
Indication DetailsTreat mild to moderate atopic dermatitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today